Tender Notice for the Cold Storage Project of Building No. 9, Minhai Biotechnology’s Internationalization Industrial Base for Novel Vaccines

Release date:

2021-05-11

Author:

Source:


Abstract

1. Project Overview 1.1. Basic Project Information Construction Entity: Beijing Minhai Biotechnology Co., Ltd. Project Name: Cold Storage Construction Project for Building No. 9 of the Minhai Biotechnology International Vaccine Industrial Base Project Overview: As part of the Minhai Biotechnology International Vaccine Industrial Base project, which is being developed with investment from Beijing Minhai Biotechnology Co., Ltd., this cold storage facility is located on the west side of the site. The project encompasses the construction of a total of 22 cold storage rooms and cool storage rooms across the basement, first, second, and third floors of Building No. 9, thereby meeting the various operational requirements of the new base. 1.2. Project Planning Conditions Cold Storage Types: 2–8°C cold storage and −20°C cold storage.

1. Project Overview

1.1. Project Overview

Construction Entity: Beijing Minhai Biotechnology Co., Ltd.

Project Name: Minhai Biologics’ International Industrial Base for Novel Vaccines 9 Cold Storage Construction Project for Building No. ___

Project Overview: Within the Minhai Biotechnology New‑Type Vaccine Internationalization Industrial Base Construction Project, which is invested in and developed by Beijing Minhai Biotechnology Co., Ltd. 9 The cold storage facility for Building No. X is located on the west side of the base, and this project primarily involves… 9 The basement, first floor, second floor, and third floor of Building No. ___ total… 22 Construction of a cold storage facility and a cool storage warehouse to meet the various requirements of the new base.

1.2. Project Planning Conditions

Cold storage type: 2--8 °C Cold storage and -20 °C Cold storage and <20 °C Cool Storage

Usage: Finished goods warehouse, raw and auxiliary materials warehouse, and semi-finished goods warehouse

Total number of cold storage facilities: 22 one

Estimated total area: 4908.71 m²

Estimated total volume: calculated based on actual measurements (with some cold storage areas having higher ceiling heights).

Compliance Requirements: Compliant with Chinese regulations. GMP ( 2010 (Revised in [Year]) and its appendices

            In compliance with the Chinese Guidelines for Pharmaceutical Production Validation ( 2003 Edition)

            Compliant with GEP Good Engineering Practice Standards

Cold storage insulation panels comply with A Fire‑resistance requirements at the specified level shall be addressed through corresponding design solutions in coordination with the design institute’s drawings.

Other requirements: Design the cold storage height according to the floor level to meet operational needs, and select materials with due consideration of thermal insulation, load-bearing capacity, and structural strength.

2. Scope and Quantity of Cold Storage Construction

2.1.9 Cold storage conditions and quantity in the basement of Building No. :

l According to the fire compartments and cold storage temperatures: Based on the fire compartments of the basement level, construct cold storage partition walls; and, in accordance with the cold storage temperature requirements, delineate the cold storage areas. 2--8 °C Cold Storage 3 one, -20 °C Cold storage facility 3 one, <20 °C Cool Storage 1 one

l Select the board thickness and material based on the actual thermal insulation performance.

2.2  9 Cold storage conditions and quantities for the first, second, and third floors of the above‑ground portion of Building No. ___: Temperature requirements for the above‑ground cold storage. 2---8 °C, Quantity: 4 on the first floor One; five on the second floor; six on the third floor.

2.3 Scope of Construction (specific floor area see the table below):

l Construction of the cold storage walls and roof on the basement, first, second, and third floors, as well as installation of lighting fixtures, doors, and air curtains.

l Procurement and installation of refrigeration units, control systems, power distribution systems, display screens, and associated equipment for the basement, first floor, second floor, and third floor cold storage facilities;

l Installation of safety facilities, including surveillance systems, audio‑visual alarms, and anti‑self‑locking devices;

2.4  Proposed 9 Cold storage area on each floor of Building No. ___ and the total area:

Cold storage location

Cold Storage Room Number

Cold storage temperature

Gross floor area

(square meters)

Height (m)

Underground

12A-B0206

2--8 °C

177.48

According to the design institute’s drawings

Underground

12A-B0207

2--8 °C

191.4

According to the design institute’s drawings

Underground

12A-B0306

2--8 °C

122.13

According to the design institute’s drawings

Underground

12A-B0308

-20 °C

78.26

According to the design institute’s drawings

Underground

12A-B0309

-20 °C

122.85

According to the design institute’s drawings

Underground

12A-B0703

<20 °C

83.85

According to the design institute’s drawings

First floor

9B-B0101

2--8 °C

131.94

According to the design institute’s drawings

First floor

9B-B0102

2--8 °C

1446.92

According to the design institute’s drawings

First floor

9B-B0103

2--8 °C

281.69

According to the design institute’s drawings

First floor

9B-B0119

2--8 °C

27.44

According to the design institute’s drawings

Second floor

9C-A0107

2--8 °C

38

According to the design institute’s drawings

Second floor

9C-A0125

2--8 °C

 

27.44

According to the design institute’s drawings

Second floor

9C-A0209

2--8 °C

69.01

According to the design institute’s drawings

 

Second floor

9C-A0211

2--8 °C

69.78

According to the design institute’s drawings

Second floor

9C-A0212

2--8 °C

33.88

According to the design institute’s drawings

Three floors

9D-B0101

2--8 °C

45.36

According to the design institute’s drawings

Three floors

9D-B0102

2--8 °C

799.11

According to the design institute’s drawings

Three floors

9D-B0103

2--8 °C

221.08

According to the design institute’s drawings

Three floors

9D-B0107

2--8 °C

42.64

According to the design institute’s drawings

Three floors

9D-B0201

2--8 °C

39.2

According to the design institute’s drawings

Three floors

9D-B0202

2--8 °C

766.07

According to the design institute’s drawings

Total

22 one

 

4908.71

 

 

 

3. Construction Requirements

3.1. The winning bidder shall strictly comply with URS Construction is required and must comply with Chinese regulations. GMP ( 2010 (Revised in [year]) and its appendices, in compliance with GEP In accordance with sound engineering management practices, all construction work shall be completed to meet the conditions for handover; upon completion, it must conform to all specifications stipulated in the design drawings and pass verification by the designated inspection authority.

3.2. Construction must ensure a well‑planned, rational overall layout, with designs that are scientific, user‑friendly, standardized, and intelligent. Design functionality should be both simple and practical, fully taking into account users’ needs and complying with industry standards.

3.3. The construction must comply with the requirements of biopharmaceutical enterprises and feature both technological innovation and practical applicability. It should be forward-looking—leading by five years and remaining state-of-the-art for a decade—while emphasizing practicality and cost-effectiveness. Upon completion, it must not only meet operational needs but also take into account operating costs as well as maintenance and repair expenses.

3.4. The primary construction materials meet the requirements for fire safety classification, thermal insulation, and structural strength; construction must comply with applicable building standards, and the materials shall conform to design specifications and relevant codes.

4. Design Schedule

Proposed construction start date: 2021 year 10 month 1 day

Proposed construction completion date: 2021 year 12 month 01 day

5. Registration Instructions:

1. Participating organizations Must possess Qualification Requirements

  ( 1 ) Enterprise qualification requirements: Bidders shall possess independent legal personality and a valid business license, and shall enjoy a good commercial reputation. This project does not accept consortium bids, and the practice of relying on another entity’s qualifications is prohibited.

( 2 ) The bidder shall possess Grade III or higher general contracting qualification for mechanical and electrical engineering; Grade III or higher specialized qualification in waterproofing, anti-corrosion, and thermal insulation; pressure piping design qualification (GC2—refrigeration specialty); and pressure piping installation qualification (GC2—refrigeration specialty).

( 3 ) Corporate performance requirements: Enterprise 2018 year 4 month 1 Since [date], the applicant has demonstrated comparable construction project experience: at least three ongoing or completed projects, as evidenced by contract dates, completion acceptance reports, or settlement statements.

( 4 ) Project Manager Performance Requirements Project Manager 2018 year 4 month 1 Has similar engineering construction experience since [date].

( 5 ) Credit requirements: The enterprise is not subject to an order to suspend operations, has not had its bidding qualifications revoked, nor is its property under receivership, frozen, or in bankruptcy; furthermore, the enterprise has not been found to have engaged in fraudulent practices to secure a bid, committed serious breaches of contract, or caused major incidents involving engineering quality or workplace safety, and is not currently within a suspension period imposed by the relevant authorities.

2 The tendering entity will review the qualification documents of all registered entities, giving priority to those with relevant project experience, and will conduct further discussions and on-site inspections with the shortlisted candidates.

3 Beijing Minhai Biotechnology Co., Ltd. was established in 2004 Year is a wholly owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. (a publicly listed company). For more information, please visit the company’s website. Our website address is: http://www.biominhai.com/

6.  Registration method:

1 The bidder shall send the registration email and electronic copies of the relevant qualification documents to the registration email address, and mail the hard copies to the procuring entity.

Registration Email mhzb@biominhai.com

Shipping Address: Simiao Road, Biomedical Industry Base, Daxing District, Beijing 35 Number

Recipient: New Project Department of Beijing Minhai Biotechnology Co., Ltd. Mr. Yang

2 , Qualification Documents:

(1) Registration requires providing the contact person and contact information of the submitting organization. The contact person must be the project leader or an designated business liaison, and must also provide… 12 Monthly social security certificate;

(2) Original identity card of the legal representative or authorized representative;

(3) Applicant’s Basic Information Form;

(4) Original and photocopies of the enterprise qualification certificate and the safety production license, stamped with the enterprise’s valid seal;

(5) Original and photocopies of the business license (certified as valid upon annual inspection), the organization code certificate, the tax registration certificate, and other aforementioned documents, all bearing the company’s official seal.

(6) Audited financial statements for the enterprise for the past three years, along with a bank‑issued or accredited credit rating. 2021 The annual credit limit available for use.

(7) Project Manager’s CV and the applicant’s track record of similar projects completed at this company over the past three years: Attach the award notification letter. ( or directly submit the subcontracting filing procedures ) Original and photocopies of completed similar project contracts, stamped with the company’s official seal; original and photocopies of the project manager’s and key management personnel’s qualification certificates, also stamped with the company’s official seal.

(8) Photocopies of the labor contracts and social insurance payment certificates for all registered personnel (including the authorized representative, project manager, and key management personnel), stamped with the official seal of the registering entity;

(9) Applicant’s Undertaking Letter (certifying that all submitted documents and credentials are true, accurate, complete, and valid);

All photocopies of the aforementioned documents must be stamped with the company’s official seal and bound in a simple manner.

3 , Contact Information:

Contact: Mr. Yang, New Engineering Project Department; Contact Number: 13261898085

7. Registration deadline: 2021 year 5 month 25 day

 

Hereby announced!

Tendering Entity: Beijing Minhai Biotechnology Co., Ltd.

                  2021 year 05 month 10 day

 

 

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09